Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prevention of thrombosis in polycythemia vera and essential thrombocythemia.

× No keyword cloud information.

12 in total

1. Two cases of pediatric essential thrombocythemia managed effectively with hydroxyurea.

Authors: Vikas Dua; Satya Prakash Yadav; Vijay Kumar; Renu Saxena; Anupam Sachdeva
Journal: Int J Hematol Date: 2012-10-07 Impact factor: 2.490

Review 2. Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders.

Authors: Martha L Cruz; Shama Farooq; Fernando D Testai
Journal: Curr Neurol Neurosci Rep Date: 2017-03 Impact factor: 5.081

3. Analysis of thrombosis and bleeding complications in patients with polycythemia vera: a Turkish retrospective study.

Authors: A M Yesilova; S Yavuzer; H Yavuzer; M Cengiz; I D Toprak; E Hanedar; M C Ar; Z Baslar
Journal: Int J Hematol Date: 2016-10-03 Impact factor: 2.490

4. Superior vena cava syndrome in a patient with polycytemia vera: diagnosis and treatment.

Authors: Salvatore Lentini; Mario Barone; Filippo Benedetto; Francesco Spinelli
Journal: Cardiol Res Pract Date: 2010-06-03 Impact factor: 1.866

5. Prevalence of venous thromboembolism in patients with secondary polycythemia.

Authors: Omar Nadeem; Jiang Gui; Deborah L Ornstein
Journal: Clin Appl Thromb Hemost Date: 2012-09-23 Impact factor: 2.389

6. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.

Authors: Ayako Kamiunten; Kotaro Shide; Takuro Kameda; Masaaki Sekine; Yoko Kubuki; Masafumi Ito; Takanori Toyama; Noriaki Kawano; Kousuke Marutsuka; Kouichi Maeda; Masanori Takeuchi; Hiroshi Kawano; Seiichi Sato; Junzo Ishizaki; Keiichi Akizuki; Yuki Tahira; Haruko Shimoda; Tomonori Hidaka; Kiyoshi Yamashita; Hitoshi Matsuoka; Kazuya Shimoda
Journal: Int J Hematol Date: 2018-02-27 Impact factor: 2.490

7. The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia.

Authors: Danijela Lekovic; Mirjana Gotic; Natasa Milic; Predrag Miljic; Mirjana Mitrovic; Vladan Cokic; Ivo Elezovic
Journal: Med Oncol Date: 2014-09-16 Impact factor: 3.064

8. The CYTO-PV: A Large-Scale Trial Testing the Intensity of CYTOreductive Therapy to Prevent Cardiovascular Events in Patients with Polycythemia Vera.

Authors: Roberto Marchioli; Guido Finazzi; Giorgina Specchia; Arianna Masciulli; Maria Rosaria Mennitto; Tiziano Barbui
Journal: Thrombosis Date: 2011-05-17

9. Philadelphia-negative chronic myeloproliferative neoplasms.

Authors: Rosane Isabel Bittencourt; Jose Vassallo; Maria de Lourdes Lopes Ferrari Chauffaille; Sandra Guerra Xavier; Katia Borgia Pagnano; Ana Clara Kneese Nascimento; Carmino Antonio De Souza; Carlos Sergio Chiattone
Journal: Rev Bras Hematol Hemoter Date: 2012

10. IRF4 and IRF8 expression are associated with clinical phenotype and clinico-hematological response to hydroxyurea in essential thrombocythemia.

Authors: Xiao Huang; Tingting Ma; Yongmei Zhu; Bo Jiao; Shanhe Yu; Kankan Wang; Jian-Qing Mi; Ruibao Ren
Journal: Front Med Date: 2021-07-31 Impact factor: 9.927